177 related articles for article (PubMed ID: 6233921)
1. Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy.
Dienstag JL; Werner BG; Polk BF; Snydman DR; Craven DE; Platt R; Crumpacker CS; Ouellet-Hellstrom R; Grady GF
Ann Intern Med; 1984 Jul; 101(1):34-40. PubMed ID: 6233921
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection.
Szmuness W; Stevens CE; Harley EJ; Zang EA; Alter HJ; Taylor PE; DeVera A; Chen GT; Kellner A
N Engl J Med; 1982 Dec; 307(24):1481-6. PubMed ID: 6755247
[TBL] [Abstract][Full Text] [Related]
3. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men.
Francis DP; Hadler SC; Thompson SE; Maynard JE; Ostrow DG; Altman N; Braff EH; O'Malley P; Hawkins D; Judson FN; Penley K; Nylund T; Christie G; Meyers F; Moore JN; Gardner A; Doto IL; Miller JH; Reynolds GH; Murphy BL; Schable CA; Clark BT; Curran JW; Redeker AG
Ann Intern Med; 1982 Sep; 97(3):362-6. PubMed ID: 6810736
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.
Stevens CE; Alter HJ; Taylor PE; Zang EA; Harley EJ; Szmuness W
N Engl J Med; 1984 Aug; 311(8):496-501. PubMed ID: 6235453
[TBL] [Abstract][Full Text] [Related]
5. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.
Wong VC; Ip HM; Reesink HW; Lelie PN; Reerink-Brongers EE; Yeung CY; Ma HK
Lancet; 1984 Apr; 1(8383):921-6. PubMed ID: 6143868
[TBL] [Abstract][Full Text] [Related]
6. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.
Szmuness W; Stevens CE; Zang EA; Harley EJ; Kellner A
Hepatology; 1981; 1(5):377-85. PubMed ID: 7030902
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hepatitis B infection in health care workers after accidental exposure.
Palmović D
J Infect; 1987 Nov; 15(3):221-4. PubMed ID: 2961815
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.
Szmuness W; Stevens CE; Harley EJ; Zang EA; Oleszko WR; William DC; Sadovsky R; Morrison JM; Kellner A
N Engl J Med; 1980 Oct; 303(15):833-41. PubMed ID: 6997738
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial.
Coutinho RA; Lelie N; Albrecht-Van Lent P; Reerink-Brongers EE; Stoutjesdijk L; Dees P; Nivard J; Huisman J; Reesink HW
Br Med J (Clin Res Ed); 1983 Apr; 286(6374):1305-8. PubMed ID: 6404440
[TBL] [Abstract][Full Text] [Related]
10. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men.
Hadler SC; Francis DP; Maynard JE; Thompson SE; Judson FN; Echenberg DF; Ostrow DG; O'Malley PM; Penley KA; Altman NL
N Engl J Med; 1986 Jul; 315(4):209-14. PubMed ID: 2941687
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial.
Desmyter J; Colaert J; De Groote G; Reynders M; Reerink-Brongers EE; Lelie PN; Dees PJ; Reesink HW
Lancet; 1983 Dec; 2(8363):1323-8. PubMed ID: 6139668
[TBL] [Abstract][Full Text] [Related]
12. Comparison of safety and immunogenicity of ADW and AYW hepatitis B vaccines.
Papaevangelou GJ; Vissoulis CG; Roumeliotou-Karayannis AJ; Kolaitis N; Krugman S
J Med Virol; 1982; 9(3):231-6. PubMed ID: 7047681
[TBL] [Abstract][Full Text] [Related]
13. Antibody response to heat-inactivated hepatitis B vaccine (CLB-3 micrograms) in hemodialysis patients and occupational risk personnel: a one year follow-up.
Yoshida FT; Takahashi C; Mercadante LA; Camargo IF; Schatzmayr HG
Rev Inst Med Trop Sao Paulo; 1988; 30(1):11-6. PubMed ID: 2975824
[No Abstract] [Full Text] [Related]
14. [Humoral response in health service personnel after administration of hepatitis B vaccine Gen-H-B-Vax].
Juszczyk J; Rokossowski H; Krajewska M; Piatek A
Przegl Epidemiol; 1991; 45(1-2):11-6. PubMed ID: 1839075
[TBL] [Abstract][Full Text] [Related]
15. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients.
Crosnier J; Jungers P; Couroucé AM; Laplanche A; Benhamou E; Degos F; Lacour B; Prunet P; Cerisier Y; Guesry P
Lancet; 1981 Apr; 1(8224):797-800. PubMed ID: 6111671
[TBL] [Abstract][Full Text] [Related]
16. Vaccines for preventing hepatitis B in health-care workers.
Jefferson T; Demicheli V; Deeks J; MacMillan A; Sassi F; Pratt M
Cochrane Database Syst Rev; 2000; (2):CD000100. PubMed ID: 10796693
[TBL] [Abstract][Full Text] [Related]
17. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff.
Crosnier J; Jungers P; Couroucé AM; Laplanche A; Benhamou E; Degos F; Lacour B; Prunet P; Cerisier Y; Guesry P
Lancet; 1981 Feb; 1(8218):455-9. PubMed ID: 6110088
[TBL] [Abstract][Full Text] [Related]
18. Large-scale efficacy trials of hepatitis B vaccines in the USA: baseline data and protocols.
Szmuness W
J Med Virol; 1979; 4(4):327-40. PubMed ID: 541683
[TBL] [Abstract][Full Text] [Related]
19. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against hepatitis B in a general hospital in Israel: antibody level before vaccination and immunogenicity of vaccine.
Karpuch J; Scapa E; Eshchar J; Waron M; Bar-Shany S; Shwartz T
Isr J Med Sci; 1993 Aug; 29(8):449-52. PubMed ID: 8407270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
